American biotechnology company Moderna is seeking emergency approval for its COVID-19 vaccine after reporting it is almost 100 percent effective in preventing severe cases.
The company claims full results from a late-stage study show it was 94.1 percent effective against the disease, with no serious safety concerns.
Moderna says the vaccine is effective across all age groups and genders, and aims to prevent severe, life threatening cases of the disease.